MARTINI, Miriam
MARTINI, Miriam
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer
2008-01-01 Di Nicolantonio F; Martini M; Molinari F; Bianchi AS; Arena S; Saletti P; Mazzucchelli L; Frattini M; Siena S; Bardelli A
BRAF V600E is a determinant of sensitivity to proteasome inhibitors.
2013-01-01 Zecchin D;Boscaro V;Medico E;Barault L;Martini M;Arena S;Cancelliere C;Bartolini A;Crowley EH;Bardelli A;Gallicchio M;Di Nicolantonio F
Class II PI3K Functions in Cell Biology and Disease
2019-01-01 Gulluni, Federico; De Santis, Maria Chiara; Margaria, Jean Piero; Martini, Miriam; Hirsch, Emilio*
Cytokinetic abscission: Phosphoinositides and ESCRTs direct the final cut
2017-01-01 Gulluni, Federico; Martini, Miriam; Hirsch, Emilio
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis
2021-01-01 Costamagna, Andrea; Natalini, Dora; Leal, Maria del Pilar Camacho; Simoni, Matilde; Gozzelino, Luca; Cappello, Paola; Novelli, Francesco; Ambrogio, Chiara; Defilippi, Paola; Turco, Emilia; Giovannetti, Elisa; Hirsch, Emilio; Cabodi, Sara; Martini, Miriam
Effects of KRAS, BRAF, NRAS and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective population-based Consortium analysis
2010-01-01 De Roock W; Claes B; Bernasconi D; De Schutter J; Biesmans B; Fountzilas G; Kalogeras KT; Kotoula V; Papamichael D; Laurent-Puig P; Penault-Llorca F; Rougier P; Vincenzi B; Santini D; Tonini G; Cappuzzo F; Frattini M; Molinari F; Saletti P; De Dosso S; Martini M; Bardelli A; Siena S; Sartore-Bianchi A; Tabernero J; Macarulla T; Di Fiore F; Gangloff AO; Ciardiello F; Pfeiffer P; Qvortrup C; Hansen TP; Van Cutsem E; Piessevaux H; Lambrechts D; Delorenzi M; Tejpar S
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES
2009-01-01 Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A.
How PI3K-derived lipids control cell division
2015-01-01 Campa, Carlo C; Martini, Miriam; De Santis, Maria C; Hirsch, Emilio
The impact of COVID-19 on pancreatic cancer research and the path forward
2021-01-01 Casolino, Raffaella; Biankin, Andrew V; Corbo, Vincenzo; Upadhaya, Samik; Xin, Yu Jia; Torroni, Lorena; Braconi, Chiara; Cappello, Paola; Carbone, Carmine; Chang, David K; Giovannetti, Elisa; Lovisa, Sara; Martini, Miriam; Pea, Antonio; Piro, Geny; Milella, Michele; Scarpa, Aldo; Bassi, Claudio; Campbell, Jay
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer
2010-01-01 Sartore-Bianchi A; Bencardino K; Di Nicolantonio F; Pozzi F; Funaioli C; Gambi V; Arena S; Martini M; Lamba S; Cassingena A; Schiavo R; Bardelli A; Siena S
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers
2007-01-01 ARENA S; ISELLA C; MARTINI M; DE MARCO A; MEDICO E; BARDELLI A
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds
2007-01-01 Federica Di Nicolantonio; Sabrina Arena; Margherita Gallicchio; Miriam Martini; Davide Zecchin; Simona Flonta; Giulia Stella; Giovanni Appendino; Roberto Fantozzi; Enzo Medico; Alberto Bardelli
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer
2022-01-01 De Santis, Maria Chiara; Gozzelino, Luca; Margaria, Jean Piero; Costamagna, Andrea; Ratto, Edoardo; Gulluni, Federico; Di Gregorio, Enza; Mina, Erica; Lorito, Nicla; Bacci, Marina; Lattanzio, Rossano; Sala, Gianluca; Cappello, Paola; Novelli, Francesco; Giovannetti, Elisa; Vicentini, Caterina; Andreani, Silvia; Delfino, Pietro; Corbo, Vincenzo; Scarpa, Aldo; Porporato, Paolo Ettore; Morandi, Andrea; Hirsch, Emilio; Martini, Miriam
Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer
2015-01-01 Costa C;Ebi H;Martini M;Beausoleil SA;Faber AC;Jakubik CT;Huang A;Wang Y;Nishtala M;Hall B;Rikova K;Zhao J;Hirsch E;Benes CH;Engelman JA
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function
2017-01-01 Gulluni, Federico; Martini, Miriam; De Santis, Maria Chiara; Campa, Carlo Cosimo; Ghigo, Alessandra; Margaria, Jean Piero; Ciraolo, Elisa; Franco, Irene; Ala, Ugo; Annaratone, Laura; Disalvatore, Davide; Bertalot, Giovanni; Viale, Giuseppe; Noatynska, Anna; Compagno, Mara; Sigismund, Sara; Montemurro, Filippo; Thelen, Marcus; Fan, Fan; Meraldi, Patrick; Marchiò, Caterina; Pece, Salvatore; Sapino, Anna; Chiarle, Roberto; Di Fiore, Pier Paolo; Hirsch, Emilio
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis
2013-01-01 M. Martini; M. Russo; S. Lamba; E. Vitiello; E. H. Crowley; F. Sassi; D. Romanelli; M. Frattini; A. Marchetti; A. Bardelli
MLK4 gene, a new diagnostic and prognostic marker in cancers
2010-01-01 Alberto Bardelli; Miriam Martini
Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells
2013-01-01 Zecchin D; Arena S; Martini M; Sassi F; Pisacane A; Di Nicolantonio F; Bardelli A.
Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer
2009-01-01 Sartore-Bianchi A*; Di Nicolantonio F*; Nichelatti M; Molinari F; De Dosso S; Saletti P; Martini M; Cipani T; Marrapese G; Mazzucchelli L; Lamba S; Veronese S; Frattini M; Bardelli A;^ Siena S^ (*shared first authorship; ^shared last authorship)
A novel multiplex qrt-pcr assay to detect sars-cov-2 infection: High sensitivity and increased testing capacity
2020-01-01 Petrillo S.; Carrà Giovanna; Bottino P.; Zanotto E.; De Santis M.C.; Margaria J.P.; Giorgio A.; Mandili G.; Martini M.; Cavallo R.; Barberio Davide; Altruda F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer | 2008 | Di Nicolantonio F; Martini M; Molinari F; Bianchi AS; Arena S; Saletti P; Mazzucchelli L; Frattini M; Siena S; Bardelli A | |
| BRAF V600E is a determinant of sensitivity to proteasome inhibitors. | 2013 | Zecchin D;Boscaro V;Medico E;Barault L;Martini M;Arena S;Cancelliere C;Bartolini A;Crowley EH;Bardelli A;Gallicchio M;Di Nicolantonio F | |
| Class II PI3K Functions in Cell Biology and Disease | 2019 | Gulluni, Federico; De Santis, Maria Chiara; Margaria, Jean Piero; Martini, Miriam; Hirsch, Emilio* | |
| Cytokinetic abscission: Phosphoinositides and ESCRTs direct the final cut | 2017 | Gulluni, Federico; Martini, Miriam; Hirsch, Emilio | |
| Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis | 2021 | Costamagna, Andrea; Natalini, Dora; Leal, Maria del Pilar Camacho; Simoni, Matilde; Gozzelino, Luca; Cappello, Paola; Novelli, Francesco; Ambrogio, Chiara; Defilippi, Paola; Turco, Emilia; Giovannetti, Elisa; Hirsch, Emilio; Cabodi, Sara; Martini, Miriam | |
| Effects of KRAS, BRAF, NRAS and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective population-based Consortium analysis | 2010 | De Roock W; Claes B; Bernasconi D; De Schutter J; Biesmans B; Fountzilas G; Kalogeras KT; Kotoula V; Papamichael D; Laurent-Puig P; Penault-Llorca F; Rougier P; Vincenzi B; Santini D; Tonini G; Cappuzzo F; Frattini M; Molinari F; Saletti P; De Dosso S; Martini M; Bardelli A; Siena S; Sartore-Bianchi A; Tabernero J; Macarulla T; Di Fiore F; Gangloff AO; Ciardiello F; Pfeiffer P; Qvortrup C; Hansen TP; Van Cutsem E; Piessevaux H; Lambrechts D; Delorenzi M; Tejpar S | |
| EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES | 2009 | Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A. | |
| How PI3K-derived lipids control cell division | 2015 | Campa, Carlo C; Martini, Miriam; De Santis, Maria C; Hirsch, Emilio | |
| The impact of COVID-19 on pancreatic cancer research and the path forward | 2021 | Casolino, Raffaella; Biankin, Andrew V; Corbo, Vincenzo; Upadhaya, Samik; Xin, Yu Jia; Torroni, Lorena; Braconi, Chiara; Cappello, Paola; Carbone, Carmine; Chang, David K; Giovannetti, Elisa; Lovisa, Sara; Martini, Miriam; Pea, Antonio; Piro, Geny; Milella, Michele; Scarpa, Aldo; Bassi, Claudio; Campbell, Jay | |
| Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer | 2010 | Sartore-Bianchi A; Bencardino K; Di Nicolantonio F; Pozzi F; Funaioli C; Gambi V; Arena S; Martini M; Lamba S; Cassingena A; Schiavo R; Bardelli A; Siena S | |
| Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers | 2007 | ARENA S; ISELLA C; MARTINI M; DE MARCO A; MEDICO E; BARDELLI A | |
| Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds | 2007 | Federica Di Nicolantonio; Sabrina Arena; Margherita Gallicchio; Miriam Martini; Davide Zecchin; Simona Flonta; Giulia Stella; Giovanni Appendino; Roberto Fantozzi; Enzo Medico; Alberto Bardelli | |
| Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer | 2022 | De Santis, Maria Chiara; Gozzelino, Luca; Margaria, Jean Piero; Costamagna, Andrea; Ratto, Edoardo; Gulluni, Federico; Di Gregorio, Enza; Mina, Erica; Lorito, Nicla; Bacci, Marina; Lattanzio, Rossano; Sala, Gianluca; Cappello, Paola; Novelli, Francesco; Giovannetti, Elisa; Vicentini, Caterina; Andreani, Silvia; Delfino, Pietro; Corbo, Vincenzo; Scarpa, Aldo; Porporato, Paolo Ettore; Morandi, Andrea; Hirsch, Emilio; Martini, Miriam | |
| Measurement of PIP3 levels reveals an unexpected role for p110β in early adaptive responses to p110α-specific inhibitors in luminal breast cancer | 2015 | Costa C;Ebi H;Martini M;Beausoleil SA;Faber AC;Jakubik CT;Huang A;Wang Y;Nishtala M;Hall B;Rikova K;Zhao J;Hirsch E;Benes CH;Engelman JA | |
| Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function | 2017 | Gulluni, Federico; Martini, Miriam; De Santis, Maria Chiara; Campa, Carlo Cosimo; Ghigo, Alessandra; Margaria, Jean Piero; Ciraolo, Elisa; Franco, Irene; Ala, Ugo; Annaratone, Laura; Disalvatore, Davide; Bertalot, Giovanni; Viale, Giuseppe; Noatynska, Anna; Compagno, Mara; Sigismund, Sara; Montemurro, Filippo; Thelen, Marcus; Fan, Fan; Meraldi, Patrick; Marchiò, Caterina; Pece, Salvatore; Sapino, Anna; Chiarle, Roberto; Di Fiore, Pier Paolo; Hirsch, Emilio | |
| Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis | 2013 | M. Martini; M. Russo; S. Lamba; E. Vitiello; E. H. Crowley; F. Sassi; D. Romanelli; M. Frattini; A. Marchetti; A. Bardelli | |
| MLK4 gene, a new diagnostic and prognostic marker in cancers | 2010 | Alberto Bardelli; Miriam Martini | |
| Modeling tumor progression by the sequential introduction of genetic alterations into the genome of human normal cells | 2013 | Zecchin D; Arena S; Martini M; Sassi F; Pisacane A; Di Nicolantonio F; Bardelli A. | |
| Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer | 2009 | Sartore-Bianchi A*; Di Nicolantonio F*; Nichelatti M; Molinari F; De Dosso S; Saletti P; Martini M; Cipani T; Marrapese G; Mazzucchelli L; Lamba S; Veronese S; Frattini M; Bardelli A;^ Siena S^ (*shared first authorship; ^shared last authorship) | |
| A novel multiplex qrt-pcr assay to detect sars-cov-2 infection: High sensitivity and increased testing capacity | 2020 | Petrillo S.; Carrà Giovanna; Bottino P.; Zanotto E.; De Santis M.C.; Margaria J.P.; Giorgio A.; Mandili G.; Martini M.; Cavallo R.; Barberio Davide; Altruda F. |